RJA
IFRX icon

Raymond James & Associates’s InflaRx IFRX Stock Holding History

Raymond James & Associates’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$409K Sell
267,075
-24,774
-8% -$37.7K ﹤0.01% 3222
2024
Q2 		$508K Buy
291,849
+49,229
+20% +$72.3K ﹤0.01% 3067
2024
Q1 		$374K Buy
242,620
+67,341
+38% +$110K ﹤0.01% 3249
2023
Q4 		$286K Buy
175,279
+12,873
+8% +$22.1K ﹤0.01% 3311
2023
Q3 		$484K Buy
162,406
+25,350
+18% +$96.5K ﹤0.01% 2919
2023
Q2 		$611K Buy
137,056
+80,991
+144% +$363K ﹤0.01% 2802
2023
Q1 		$109K Buy
56,065
+14,942
+36% +$32.3K ﹤0.01% 3633
2022
Q4 		$127K Sell
41,123
-2,300
-5% -$5.86K ﹤0.01% 3584
2022
Q3 		$115K Buy
43,423
+4,339
+11% +$9.77K ﹤0.01% 3583
2022
Q2 		$57K Buy
39,084
+1,880
+5% +$2.86K ﹤0.01% 3777
2022
Q1 		$68K Sell
37,204
-28,338
-43% -$88.3K ﹤0.01% 3883
2021
Q4 		$312K Buy
65,542
+55,123
+529% +$222K ﹤0.01% 3415
2021
Q3 		$27K Sell
10,419
-9,500
-48% -$25K ﹤0.01% 3974
2021
Q2 		$59K Sell
19,919
-21,574
-52% -$71.5K ﹤0.01% 3900
2021
Q1 		$162K Buy
41,493
+1,228
+3% +$6.29K ﹤0.01% 3670
2020
Q4 		$203K Sell
40,265
-5,825
-13% -$26.2K ﹤0.01% 3393
2020
Q3 		$196K Buy
+46,090
New +$212K ﹤0.01% 3219

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Raymond James & Associates's IFRX Position: Q3 2024 in Review

Raymond James & Associates reduced its InflaRx (IFRX) stake by 8.5% in Q3 2024, selling an estimated $37.7K and leaving 267,075 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Raymond James & Associates first reported a position in IFRX in Q3 2020 and has held it in 17 quarters since. The position peaked at $611K in Q2 2023. 27 funds tracked by Wall St. Rank hold IFRX as of Q3 2024.

  • Raymond James & Associates held 267,075 shares of InflaRx worth $409K as of Q3 2024.
  • Raymond James & Associates sold 24,774 InflaRx shares in Q3 2024, an estimated $37.7K.
  • InflaRx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3222 holding.
  • Raymond James & Associates first reported a position in InflaRx in Q3 2020 and has held it in 17 quarters since.
  • Raymond James & Associates's InflaRx position peaked at $611K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.